Avita has their own patents and entered the US market in January 2019 after receiving FDA PMA approval for treating 2nd and 3rd degree burns. They have 2 other clinical trials in progress - both of which are being funded by BARDA (US Government) at a cost of $25 million. They're moving into the pediatrics space for treating scald wounds and also for rapid healing of areas that were harvested for skin grafting. They are light years ahead of Renovacare and fully funded for several other clinical trials. They've also derisked their pipeline via smaller studies that clearly show their product works for other applications. There is no contest between the 2 companies - 1 is the real deal, while the other is a publicity machine looking to increase their price via headlines - but nothing of substance behind them.
Check out Avita Medical's website - you'll be glad you did!
News 
Market Data 
Discover 
